managed dsip ii equity strategy Why DEI in Private Matters More Than Ever A surprising deal from Vertex
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked Separating Apples from Pears The Hedge Fund Journal Private Equity Data Management Software Semarchy Reimagining the 60 40 Portfolio with Private Equity Secondaries
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

